Better Cancer Free: The Controversy Over Prostate Cancer Screening

Better Cancer Free: The Controversy Over Prostate Cancer Screening Listen To This Episode on Apple Podcasts

In this episode, we discuss prostate cancer screening. Prostate cancer is the most common cancer in men and yet screening for prostate cancer is considered quite controversial. Many sources state that prostate cancer is slow growing and that, as a result, prostate cancer screening is just not warranted. At the same time, prostate cancer takes the lives of about 34,000 American men every year. So what should guys do? Who should get screened? What does that even entail? Are there options as to how to get screened? Are there risks involved? To help us sort through these questions we turn to a true expert,

This Episode's Guest:
Ganesh Palapattu, MD

Dr. Ganesh Palapattu is professor and chairman of the Department of Urology at the University of Michigan. Dr. Palapattu completed his undergraduate studies at the University of Texas at Austin and earned his medical degree from the Baylor College of Medicine. He underwent his residency training in urology at UCLA and then completed a fellowship in urologic oncology at Johns Hopkins. After completing his training Dr. Palapattu held a faculty appointment at the University of Rochester School of Medicine, and then served as the chief of urologic oncology at the Methodist Hospital in Houston, Texas. In 2012, Dr. Palapattu was appointed associate professor and chief of urologic oncology at the University of Michigan, where he later became chair of the urology department.